SCHEMBL4779679

SCHEMBL4779679

COCCNc1nc(N)nc2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.71
CYP1A2 P05177 9/20 0.62
CYP3A4 P08684 9/20 0.62
HSD17B10 Q99714 4/20 0.62
KDM4E B2RXH2 2/20 0.62
LDHA P00338 1/20 0.61
CYP2C19 P33261 4/20 0.61
USP2 O75604 4/20 0.61
CYP2D6 P10635 4/20 0.61
CLK4 Q9HAZ1 3/20 0.61
ALDH1A1 P00352 2/20 0.61
ALOX15 P16050 2/20 0.61
MAPK1 P28482 1/20 0.61
NCF1 P14598 1/20 0.60
TLR8 Q9NR97 1/20 0.60
TLR7 Q9NYK1 1/20 0.60
TSHR P16473 4/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
LMNA P02545 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5534962 0.82 CYP1A2 (0.62) APPCYP1A2CYP3A4HSD17B10KDM4E
SCHEMBL8897898 0.82 CYP1A2 (0.68) APPCYP1A2CYP3A4HSD17B10KDM4E
SCHEMBL4358305 0.82 TLR7 (0.54) APPCYP1A2CYP3A4HSD17B10KDM4E
SCHEMBL10838568 0.81 APP (0.74) APP
SCHEMBL1084153 0.81 CYP1A2 (0.79) CYP1A2CYP3A4HSD17B10KDM4ECYP2C19
SCHEMBL23513886 0.81 TLR7 (0.47) APPCYP1A2CYP3A4HSD17B10KDM4E
SCHEMBL29653748 0.81 TLR7 (0.47) APPCYP1A2CYP3A4HSD17B10KDM4E
SCHEMBL13975549 0.81 APP (0.83) APPCYP1A2CYP2D6TLR8TLR7
SCHEMBL28414968 0.80 LDHA (0.62) APPCYP1A2CYP3A4HSD17B10KDM4E
SCHEMBL4867969 0.78 MAPT (0.59) CYP1A2CYP3A4HSD17B10KDM4ELDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008009078-A2 4,6-DL- AND 2,4,6-TRISUBSTITUTED QUINAZOLINE DERIVATIVES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC. (US) 2008-01-24 WO disclosed